Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 441,994 shares at $54.21 ($23.7M) on 2025-09-16, disclosed to the SEC on 2025-09-17.
Scheduled sale ($23.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.96 | 90,672 | $4.9M | 20.7% |
| 2 | $52.90 | 28,652 | $1.5M | 6.4% |
| 3 | $52.90 | 28,652 | $1.5M | 6.4% |
| 4 | $53.03 | 32,190 | $1.7M | 7.2% |
| 5 | $53.03 | 32,190 | $1.7M | 7.2% |
| 6 | $53.08 | 23,938 |
| $1.3M |
| 5.4% |
| 7 | $53.08 | 23,938 | $1.3M | 5.4% |
| 8 | $53.79 | 17,001 | $914K | 3.9% |
| 9 | $53.79 | 17,001 | $914K | 3.9% |
| 10 | $53.79 | 16,667 | $897K | 3.8% |
| 11 | $53.79 | 16,667 | $897K | 3.8% |
| 12 | $53.81 | 17,810 | $958K | 4.1% |
| 13 | $53.81 | 17,810 | $958K | 4.1% |
| 14 | $53.81 | 17,729 | $954K | 4.0% |
| 15 | $53.81 | 17,729 | $954K | 4.0% |
| 16 | $53.85 | 18,882 | $1.0M | 4.3% |
| 17 | $53.85 | 18,882 | $1.0M | 4.3% |
| 18 | $54.21 | 2,792 | $151K | 0.6% |
| 19 | $54.21 | 2,792 | $151K | 0.6% |
| Total | $53.54 avg | 441,994 | $23.7M | 100% |
| Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |
| HIMS | SELL | 2025-07-23 | $9.9M | — | Filing → |